Segmentation by type classifies root canal irrigants into chemical families that differ in antimicrobial potency, tissue dissolution capacity, and safety profile. Sodium hypochlorite remains the market leader, valued for its broad‑spectrum disinfection and superior organic tissue dissolution, contributing the largest revenue slice despite concentration‑related handling concerns. Chlorhexidine gluconate occupies a secondary tier, favored for its substantivity and lower cytotoxicity, especially in patients with hypersensitivity to sodium hypochlorite. Ethylenediaminetetraacetic acid (EDTA) serves a distinct role in smear‑layer removal and is often paired with other agents, generating a niche but essential revenue stream. MTAD (a mixture of doxycycline, citric acid, and a detergent) targets cases requiring both antimicrobial action and smear‑layer management, representing a specialized segment. Emerging formulations such as nanoparticle‑enhanced irrigants and bioceramic solutions are gaining traction, adding incremental growth potential. Each type’s market contribution aligns with clinical preferences, regulatory acceptance, and cost considerations, shaping the overall taxonomy of the Root Canal Irrigatos market.